Jim Lavery Law Limited
JLL is a firm of solicitors with authorisation from the Solicitors Regulation Authority, offering legal advisory work from a Midlands base.
JLL delivers legal advice across a wide range of corporate and company issues, including acting for management teams as well as working with other law firms to provide independent advice where a conflict of interest has been identified. With a very strong reputation as a highly experienced and commercial practitioner, law firms can introduce JLL, safe in the knowledge that their best and most important clients are being well looked after on a cost-effective basis and without interference to the underlying law firm/client relationship.
JLL works and has in-depth knowledge in a wide variety of industry sectors with particular expertise in Manufacturing, Technology, Energy/Waste and Life Sciences, having acted on a number of deals in those fields.
Manufacturing: acted for the institutional shareholders of Stadco on its sale to Magna International and for Goodrich/UTC on the acquisitions of Crompton Technology and Microtecnica. Advised the management team of Bromford Industries on the leveraged buy out by Liberty Hall And Calder Group on its capital structure as well as multiple acquisitions in the UK and in continental Europe.
Technology: including the acquisitions of Virgin Media’s stake in UKTV and Travel Channel International on behalf of Scripps Network Interactive, the disposal of Specialist Distribution Group for Specialist Computer Holdings and the sale of Epyx to Fleetcor.
Energy/Waste: acted for Metal & Waste Recycling on numerous acquisitions and disposals since 2006, leading the acquisition of Green Sky Energy for E.ON and advising GE Power & Water on two acquisitions in the UK and Holland as well as Cameron International on acquisitions in the UK, Italy Germany and Hungary.
Life Sciences: acted for Femcare, Summit Medical and Premier Care for a number of years. Advised Livingbridge on the acquisition of Surgi C and the disposal of Scriptswitch. Acted for Norgine on the disposal of a number of international pharmaceutical product licences.
